Company page
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. is a public company traded under the ticker LYEL on the American market. The company has a market capitalization of approximately $297.3 million. Lyell focuses on developing innovative immunotherapies for cancer treatment.
- Ticker
- LYEL:NASDAQ
- Asset type
- Stock
- Market cap
- $297.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD